UNSPSC 51283719: Cefonicid sodium

This classification denotes a cephalosporin antibiotic with the molecular formula C18H16N6O8S3.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F74MFL78A1, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((hydroxyphenylacetyl)amino)-8-oxo-3-(((1-(sulfomethyl)-1h-tetrazol-5-yl)thio)methyl)disodium salt, (6r-(6alpha,7beta(r*))) but more generally known as cefonicid sodium, which bears US NIH Compound Identifier 43593.

Most nations, for tariff and trade purposes, schedule cefonicid sodium under HS 29419000 and SITC 54139. As of Q4 2014, CEFONICID SODIUM remains US FDA's Preferred Term for this commodity. Cefonicid sodium bears US NLM identifiers UMLS ID C0886812 and NCI Concept Code C65300. SMILES: C1CCC(CC1)[C@H](C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)CSC4NNNN4CS(=O)(=O)[O-])C(=O)[O-])O.[NA+].[NA+].

UNSPSC 51283719 Cefonicid sodium is a Commodity code with minimal recent state and local procurement activity directly aligned to the code's pharmaceutical scope. The code shows little relevant recent activity; the state and local opportunities tagged to this code instead reflect procurement of naloxone, emergency medical supplies, generic pharmaceuticals, and pharmacy benefit management services—distinct product categories and service delivery models that do not correspond to cefonicid sodium, an antibiotic agent. State and local buying under pharmaceutical commodity codes at this specificity tier typically involves standardized drug procurement through wholesalers, group purchasing organizations, and multi-jurisdictional cooperative agreements, yet the recent opportunities on file reflect broader medical supply, emergency response, and pharmacy network initiatives rather than targeted acquisition of a single pharmaceutical ingredient or formulation.

The geographic spread of recent pharmaceutical and medical supply solicitations includes Florida, Texas, and Minnesota, with the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) representing multi-state coordination across participating jurisdictions including Oregon. Representative recent opportunities include Seminole County, Florida's procurement of naloxone and drug deactivation systems through IFB 60459723LAS (due July 26, 2023) with quarterly deliveries to a county health facility; the City of Tampa Fire Department's IFB 26P00145 for medical and first aid supplies (estimated value $700,000, due March 13, 2026, sheltered for certified Small Local Business Enterprises); the Texas Health and Human Services Commission's RFI HHS0017013 regarding direct-to-manufacturer prescription programs (response deadline April 3, 2026); and MMCAP's RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products through authorized wholesalers (due March 26, 2026, with contract effectiveness July 1, 2026). The absence of targeted cefonicid sodium solicitations suggests minimal current demand or procurement volume under this specific commodity code at the state and local level.